目前治疗脏移植接受者的勃起功能障碍的选择
1Unit of Quality and Risk Management, Division of Urology, University Hospital of Marche, Ancona, 60126, Italy.
Sexual medicine reviews
|May 9, 2024
概括
勃起功能障碍 (ED) 在移植接受者 (KTR) 中很常见. 像PDE5抑制剂,丸激素,冲击波疗法和植入物等治疗方法为KTRs的ED提供了有效的解决方案.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 腎臟病學 (nephrology) 是一種醫學專業.
- 安德罗学与人类学
背景情况:
- 勃起功能障碍 (ED) 和功能障碍有共同的风险因素,包括内皮功能障碍.
- 慢性病 (CKD) 显著增加了ED的发病率和流行率.
- 一个很大的比例的移植接受者 (KTRs) 继续经历ED移植后 (20%-50%).
研究的目的:
- 对KTRs中ED的当前治疗方式进行审查.
- 在KTRs中评估各种ED治疗的临床结果.
主要方法:
- 一个关于相关文献的叙事评论.
- 在MEDLINE,科学网,PubMed和谷歌学者中进行的搜索.
- 评价 64 个选定的文章.
主要成果:
- 在KTR中ED具有多因素的病因,包括心理,药物,血管和内分泌因素.
- 多种治疗选择,包括药物治疗,洞内注射,真空装置和体外冲击波治疗,对于KTR来说是安全有效的.
- 身体外冲击波疗法对第一线治疗反应不良的人来说是有希望的.
结论:
- 在KTR患者的初始ED治疗可能涉及低剂量的固酶5型 (PDE5) 抑制剂,特别是与同时存在的阴性腺症.
- 与和PDE5抑制剂的联合治疗可能提供协同效益.
- 阴茎植入物是KTRs的第三线选择,根据个体患者的需求和临床适用性进行考虑.
相关概念视频
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
146
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
146
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
155
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
155
01:20Disorders of the Male Reproductive System
397
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
397
01:22Heart Failure Drugs: Diuretics
367
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
367
01:27Dialysis
301
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
301